---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-003122"
form_type: "8-K"
ticker: "PAYS"
cik: "0001496443"
company_name: "Paysign, Inc."
filed_at: "2023-05-10T23:59:59+00:00"
generated_at: "2026-06-15T06:13:58.606639+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Paysign Q1 rev +23% to $10.1M, net loss narrows; Q2 guidance calls for continued growth

## Summary
- Q1 2023 revenues $10.1M (+23% YoY); net loss $0.2M improved from $0.3M loss a year ago.
- Adjusted EBITDA $0.7M (down 22% YoY); guided Q2 rev growth 15-20%, Adj. EBITDA growth 5-10%.
- Added 10 plasma centers (total 439); launched 7 pharma copay programs (total 26); gross spend +31%.
- Unrestricted cash $6.4M (down $3.3M from Dec 2022) due to AR build, capex, and $0.7M stock buyback.
- Gross margin fell to 49.8% from 60.8% on higher third-party costs and mix shift toward lower-margin plasma.

## SEC filing metadata
- accession: 0001683168-23-003122
- form_type: 8-K
- ticker: PAYS
- cik: 0001496443
- company_name: Paysign, Inc.
- filed_at: 2023-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1496443/000168316823003122/0001683168-23-003122-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1496443/000168316823003122/paysign_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-003122
- JSON: https://secwatch.observer/filing/0001683168-23-003122.json
- Plain text: https://secwatch.observer/filing/0001683168-23-003122.txt

## Key facts
- Earnings Releases
  Paysign, Inc. reported first quarter 2023 results: revenue $10.1 million, net income ($0.2) million, EPS ($0.00) per diluted share.
  - Period: first quarter 2023
  - Revenue: $10.1 million
  - Net income: ($0.2) million
  - EPS: ($0.00) per diluted share
  - Result: reported results
  source text: First quarter total revenues of $10.1 million, up 23% from first quarter 2022 · First quarter net loss of ($0.2) million, or diluted loss per share of ($0.00)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1496443/000168316823003122/0001683168-23-003122-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.